Menopause
📧 Sign up to get email alerts when something new happens for Menopause.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-02-27Clinical Trial Update: Gabapentin for Insomnia Symptoms and Nighttime Vasomotor Symptoms (VMS) in Peri- and Postmenopausal Women [NA]
Clinical trial investigating gabapentin for insomnia symptoms and nighttime vasomotor symptoms in peri- and postmenopausal women has complet…
-
CLINICAL_TRIALS trial_result · 2017-02-23Clinical Trial Update: Bleed Free Treatment of Menopausal Symptoms With New Ultra Low Dose Hormonal Combinations [Phase 3]
Phase 3 trial update for a bleed-free, ultra-low-dose hormonal combination aimed at menopausal vasomotor symptoms; the study status is compl…
-
FDA approval · 2017-02-10FDA Approved: ABIGALE LO — Original Application (Xiromed LLC)
FDA approved ABIGALE LO, a generic combination of estradiol and norethindrone acetate, under an Original Application by Xiromed LLC. It is a…
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Pharmacokinetic Assessment of the Absorption of Estradiol in Postmenopausal Women With Atrophic Vaginitis [Phase 1]
Phase 1 pharmacokinetic study assessing the absorption of estradiol in postmenopausal women with vaginal atrophy; the study has completed.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Vagifem® Used for the Treatment of Atrophic Vaginitis Due to Oestrogen Deficiency
Vagifem (estradiol vaginal tablet) was studied for the treatment of atrophic vaginitis due to estrogen deficiency in postmenopausal women. T…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-02-08Clinical Trial Update: Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms [Phase 3]
Phase 3 trial update indicates Vagifem Low Dose for postmenopausal vaginal atrophy has completed.
-
CLINICAL_TRIALS research · 2017-01-26Clinical Trial Update: Evaluation of the Effect of Transcutaneous Electrical Nerve Stimulation (TENS) in Postmenopausal Women [Phase 1, Phase 2]
This clinical trial evaluates the effect of transcutaneous electrical nerve stimulation (TENS) in postmenopausal women. The study is in Phas…
-
CLINICAL_TRIALS research · 2017-01-11Clinical Trial Update: Following Lipectomy to Understand Adipose Tissue Re-accumulation [NA]
The clinical trial update notes completion of a study investigating how adipose tissue re-accumulates after lipectomy in menopausal and pre-…
-
CLINICAL_TRIALS trial_result · 2016-12-28Clinical Trial Update: Deterioration of Resilient Denture Liners and Patient Characteristics
This clinical trial update summarizes observed deterioration of resilient denture liners and describes patient characteristics from the comp…
-
CLINICAL_TRIALS trial_result · 2016-12-06Clinical Trial Update: Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms [Phase 3]
Phase 3 trial assessing soy isoflavones to prevent bone loss and alleviate menopausal symptoms has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2016-09-16Clinical Trial Update: Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms [Phase 4]
A Phase 4 clinical trial completed comparing omega-3 fatty acids versus soy isoflavones to manage moderate-to-severe vasomotor symptoms in p…
-
CLINICAL_TRIALS trial_result · 2016-08-04Clinical Trial Update: A Study To Investigate The Effect Of A Natural Dietary Supplement On Peri-Menopausal Symptoms [Phase 2, Phase 3]
Phase 2/3 clinical trial evaluating a natural dietary supplement for peri-menopausal symptoms has been terminated. The sponsor is Physician …
-
CLINICAL_TRIALS trial_result · 2016-08-02Clinical Trial Update: Reducing Menopausal Symptoms for Women During Menopause Using Group Education in a Primary Health Care Setting [NA]
Completed clinical trial evaluating whether group education in primary care reduces menopausal symptoms in women.
-
CLINICAL_TRIALS trial_result · 2016-07-13Clinical Trial Update: Medroxyprogesterone Compared With Venlafaxine in Treating Hot Flashes in Women [Phase 3]
A Phase 3 trial comparing medroxyprogesterone acetate with venlafaxine for hot flashes in women has completed.
-
CLINICAL_TRIALS research · 2016-07-01Clinical Trial Update: The Functional Magnetic Resonance Imaging Study on the Processing of Acute Pain and Cognition Among Perimenopause Women
This clinical trial update describes an fMRI study investigating how acute pain and cognition are processed in perimenopausal women.
-
CLINICAL_TRIALS trial_result · 2016-06-30Clinical Trial Update: Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal Women [NA]
This clinical trial update reports a study evaluating a lacto-ovo-vegetarian diet enriched with omega-3 fatty acids in menopausal women, wit…
-
CLINICAL_TRIALS trial_result · 2016-05-24Clinical Trial Update: Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy [Phase 2]
A Phase 2 clinical trial comparing nanoparticulate versus micronized steroid delivery for transdermal hormone replacement in menopausal synd…
-
CLINICAL_TRIALS trial_result · 2016-05-13Clinical Trial Update: Soy Estrogen Alternative Study (SEA) [Phase 2]
The Soy Estrogen Alternative Study (SEA), a Phase 2 clinical trial sponsored by the National Heart, Lung, and Blood Institute (NHLBI), has c…
-
FDA approval · 2016-05-04FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PREMPRO, a combination of conjugated estrogens and medroxyprogesterone acetate, from Wyeth P…
-
CLINICAL_TRIALS research · 2016-04-27Clinical Trial Update: Cohort Study to Evaluate Ovarian Function
Clinical trial update describing a cohort study evaluating ovarian function, sponsored by Shixuan Wang, focusing on diminished ovarian reser…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms [Phase 3]
A Phase 3 trial evaluating oral dehydroepiandrosterone (DHEA) for postmenopausal women has completed, assessing effects on sexual function, …
-
FDA approval · 2016-02-25FDA Approved: PREMPRO — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PREMPRO (conjugated estrogens and medroxyprogesterone acetate) from Wyeth Pharmaceuticals (Pfize…
-
CLINICAL_TRIALS trial_result · 2016-01-27Clinical Trial Update: "Pi" and Hot Flushes [Phase 1, Phase 2]
A clinical trial update for Pi evaluating menopausal symptoms relief (hot flashes) in Phase 1 and Phase 2; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2016-01-22Clinical Trial Update: Neuropsychobiological Correlates of Sex-steroid Hormone Manipulation in Healthy Women: a Risk Model for Depression [NA]
This entry notes the completion of a clinical trial investigating the neuropsychobiological correlates of sex-steroid hormone manipulation i…
-
CLINICAL_TRIALS trial_result · 2016-01-15Clinical Trial Update: Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women [Phase 1]
Phase 1 bioavailability study comparing three oral formulations for hormone replacement therapy in postmenopausal women.